Sequent Scientific Ltd Nine Monthly Results

Gross Sales

1,149.67

1,008.53

1,054.24

1,029.11

1,014.75

Excise Duty

0

0

0

0

0

Net Sales

1,149.67

1,008.53

1,054.24

1,029.11

1,014.75

Other Operating Income

0

0

0

0

0

Other Income

13.03

6.96

4.65

7.08

6.99

Total Income

1,162.7

1,015.49

1,058.89

1,036.18

1,021.74

Total Expenditure

1,038.75

992.07

1,042.12

953.05

850.08

PBIDT

123.95

23.42

16.78

83.13

171.67

Interest

45.62

35.64

24.65

9.74

21.21

PBDT

78.33

-12.22

-7.87

73.39

150.46

Depreciation

50.33

45.06

40.99

38.61

37.92

Minority Interest Before NP

0

0

0

0

0

Tax

27.96

10.51

3.38

2.42

29.72

Deferred Tax

-21.84

-36.9

-22.7

-2.67

-2.7

Reported Profit After Tax

21.88

-30.89

-29.54

35.02

85.53

Minority Interest After NP

9.32

4.07

-1.95

2.74

6.12

Net Profit after Minority Interest

12.56

-34.96

-27.59

32.29

79.41

Extra-ordinary Items

-0.01

-10.35

-2.98

0

-6.65

Adjusted Profit After Extra-ordinary item

12.57

-24.61

-24.61

32.29

86.06

EPS (Unit Curr.)

0.5

-1.41

-1.11

1.31

3.24

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.06

49.89

49.89

49.67

49.67

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.78

2.32

1.59

8.07

16.91

PBDTM(%)

6.81

-1.21

-0.74

7.13

14.82

PATM(%)

1.9

-3.06

-2.8

3.4

8.42